IL7R and acute lymphoblastic leukemia: Two other anti-IL-7Rα monoclonal antibodies (4A10 and 2B8) that identify non-overlapping IL-7Rα epitopes, and can mediate antibody-dependent cell-mediated cytotoxicity and other repressive mechanisms and have curative effects on patient-derived xenograft T-ALL cells [134].